Medpace Holdings (MEDP) Cash & Equivalents Growth (3y) (2018 - 2026)
Powered by 
Analysis
Medpace Holdings (MEDP) Cash & Equivalents Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.37% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 134.19% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 50.90% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -1.42% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 13.83% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | -6.83% |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -57.56% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -3.52% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.32% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.19% |
| Mar 31, 2026 | 140.50% |
| Dec 31, 2025 | 160.05% |
| Sep 30, 2025 | 109.56% |
| Jun 30, 2025 | 2.88% |
| Mar 31, 2025 | 74.66% |
| Dec 31, 2024 | 13.22% |
| Sep 30, 2024 | 18.14% |
| Jun 30, 2024 | 14.65% |
| Mar 31, 2024 | 6.93% |
| Dec 31, 2023 | -4.04% |
| Sep 30, 2023 | -24.27% |
| Jun 30, 2023 | -37.58% |
| Mar 31, 2023 | -29.52% |
| Dec 31, 2022 | -40.16% |
| Sep 30, 2022 | -26.87% |
| Jun 30, 2022 | 28.41% |
| Mar 31, 2022 | 40.10% |
| Dec 31, 2021 | 170.62% |
| Sep 30, 2021 | 161.64% |